Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 4/20 | 0.41 |
| ▸ | TYR | P14679 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | TLR8 | Q9NR97 | 8/20 | 0.39 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5753759 | 0.84 | ALOX5 (0.52) | ALOX5TYRMEN1TP53CYP3A4 | |
| SCHEMBL543504 | 0.84 | GPR84 (0.33) | — | |
| SCHEMBL3110488 | 0.83 | ALOX5 (0.48) | ALOX5TYRMEN1TP53CYP3A4 | |
| SCHEMBL5012407 | 0.82 | ALOX5 (0.42) | ALOX5TYRMEN1TP53CYP3A4 | |
| SCHEMBL543728 | 0.81 | ALOX5 (0.41) | ALOX5TYRMEN1TP53CYP3A4 | |
| SCHEMBL28453738 | 0.77 | ALOX5 (0.47) | ALOX5TYRMEN1TP53CYP3A4 | |
| SCHEMBL28460292 | 0.77 | ALOX5 (0.47) | ALOX5TYRMEN1TP53CYP3A4 | |
| SCHEMBL5749320 | 0.77 | TLR8 (0.50) | ALOX5TYRMEN1TP53CYP3A4 | |
| SCHEMBL16807676 | 0.77 | KDM4E (0.39) | ALOX5TYRMEN1TP53CYP3A4 | |
| SCHEMBL543710 | 0.76 | GPR84 (0.41) | MAPTTLR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1719749-B1 | POLYACENE COMPOUND AND ORGANIC SEMICONDUCTOR THIN FILM | ASAHI CHEMICAL IND (JP) | 2016-08-24 | — | — | EP | disclosed |
| US-8236998-B2 | Polyacene compound and organic semiconductor thin film | ASAHI KASEI CORPORATION (JP) | 2012-08-07 | — | — | US | disclosed |
| US-20120108850-A1 | POLYACENE COMPOUND AND ORGANIC SEMICONDUCTOR THIN FILM | NAGATA KAZUTO (JP) | 2012-05-03 | — | — | US | disclosed |
| US-8110714-B2 | High mobility, solubility, oxidation resistance; transistor; drain electrodes | ASAHI KASEI CORPORATION (JP) | 2012-02-07 | — | — | US | disclosed |
| US-20080061287-A1 | Polyacene Compound And Organic Semiconductor Thin Film | ASAHI KASEI CORPORATION (JP) | 2008-03-13 | — | — | US | disclosed |
| EP-1719749-A1 | POLYACENE COMPOUND AND ORGANIC SEMICONDUCTOR THIN FILM | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 2006-11-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120108850-A1 | POLYACENE COMPOUND AND ORGANIC SEMICONDUCTOR THIN FILM | ZRANB2, PUF60, ZKSCAN2 | ALOX5 1486/4885TYR 469/4885MEN1 2970/4885 |
| US-20080061287-A1 | Polyacene Compound And Organic Semiconductor Thin Film | ZRANB2, PUF60, ZKSCAN2 | ALOX5 1486/4885TYR 469/4885MEN1 2970/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.